Concepedia

J. Rosenberg

JR

Statistics

Publications

19

Citations

5.1K

H-Index

16

Active since

1991

Affiliations

American Academy of Neurology(Current)

Uniformed Services University of the Health Sciences

Stanford University

Roswell Park Comprehensive Cancer Center

Fred Hutch Cancer Center

J. Rosenberg is an author at American Academy of Neurology specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

1991–2015

19

Publications

19

Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma

DG Maloney, TM Liles, DK Czerwinski et al. · Blood · 1994 · 753 citations

Medicine, Hematology, Oncology +17

Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment

Thomas A. Davis, Antonio J Grillo-López, Christine A. White et al. · Journal of Clinical Oncology · 2000 · 689 citations

Pharmacy, Hematology, Pharmacotherapy +15

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.

DG Maloney, A.J. Grillo-López, David Bodkin et al. · Journal of Clinical Oncology · 1997 · 638 citations

Pharmacy, Hematology, Pharmacokinetics +17

Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) [RETIRED]

Robert G. Miller, J. Rosenberg, Deborah Gelinas et al. · Neurology · 1999 · 575 citations · Full text

Life Sciences, Neurology, Clinical Neuroscience +1

Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma

Neil L. Berinstein, A.J. Grillo-López, Christine A. White et al. · Annals of Oncology · 1998 · 523 citations · Full text

Medicine, Hematology, Oncology +15

1–5 of 19